普鲁卡因酰胺N - 乙酰化代谢产物在人体中的药代动力学。 - Suppr

Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

作者信息

Strong J M, Dutcher J S, Lee W K, Atkinson A J

出版信息

J Pharmacokinet Biopharm. 1975 Aug;3(4):223-35. doi: 10.1007/BF01066919.

DOI:10.1007/BF01066919

PMID:1185521

Abstract

摘要

相似文献

Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

J Pharmacokinet Biopharm. 1975 Aug;3(4):223-35. doi: 10.1007/BF01066919.

Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology.

Clin Pharmacol Ther. 1977 Oct;22(4):447-57. doi: 10.1002/cpt1977224447.

Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man.

J Pharmacokinet Biopharm. 1975 Apr;3(2):69-76. doi: 10.1007/BF01066016.

Fetal uptake and neonatal disposition of procainamide and its acetylated metabolite: a case report.

Pediatrics. 1978 Mar;61(3):491-3. doi: 10.1542/peds.61.3.491.

Pharmacokinetics of procainamide and N-acetylprocainamide in rats.

J Pharm Sci. 1981 Mar;70(3):299-302. doi: 10.1002/jps.2600700319.

The quantitative disposition of procainamide and N-acetylprocainamide in the rat.

J Pharmacol Exp Ther. 1978 Jan;204(1):219-25.

Determination of procainamide acetylator status.

Clin Pharmacol Ther. 1978 Jan;23(1):25-9. doi: 10.1002/cpt197823125.

Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.

Int J Clin Pharmacol Ther Toxicol. 1980 Jun;18(6):272-6.

Ethanol-induced increase in procainamide acetylation in man.

Br J Clin Pharmacol. 1982 Feb;13(2):203-8. doi: 10.1111/j.1365-2125.1982.tb01357.x.

[Clinical pharmacokinetics and pharmacodynamics of novocainamide and its metabolite N-acetylnovocainamide].

Kardiologiia. 1981 Nov;21(11):119-26.

引用本文的文献

Elucidation of the pathophysiology of intradialytic muscle cramps: pharmacokinetics applied to translational research.

Transl Clin Pharmacol. 2019 Dec;27(4):119-122. doi: 10.12793/tcp.2019.27.4.119. Epub 2019 Dec 31.

Metabolomics reveals the metabolic map of procainamide in humans and mice.

Biochem Pharmacol. 2012 May 15;83(10):1435-44. doi: 10.1016/j.bcp.2012.02.013. Epub 2012 Feb 24.

A liner mode of reversible metabolism and its application to bioavailability assessment.

J Pharmacokinet Biopharm. 1981 Dec;9(6):693-709. doi: 10.1007/BF01070901.

New antiarrhythmic drugs: their place in therapy.

Drugs. 1981 Nov;22(5):363-400. doi: 10.2165/00003495-198122050-00002.

Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide.

Eur J Clin Pharmacol. 1983;25(6):791-5. doi: 10.1007/BF00542522.

Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.

Eur J Clin Pharmacol. 1983;25(3):339-45. doi: 10.1007/BF01037945.

Clinical pharmacokinetics of N-acetylprocainamide.

Clin Pharmacokinet. 1982 May-Jun;7(3):206-20. doi: 10.2165/00003088-198207030-00002.

A nonlinear physiologic pharmacokinetic model: I. Steady-state.

J Pharmacokinet Biopharm. 1985 Feb;13(1):73-92. doi: 10.1007/BF01073657.

Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.

Drugs. 1990 May;39(5):720-40. doi: 10.2165/00003495-199039050-00007.

Comparison of the acetylation of procainamide and sulfadimidine in man.

Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):433-8. doi: 10.1007/BF00606561.

本文引用的文献

Acetylation of procaine amide in man studied with a new gas chromatographic method.

Br J Clin Pharmacol. 1974 Dec;1(6):467-75. doi: 10.1111/j.1365-2125.1974.tb01696.x.

The fate of procaine in man following its intravenous administration and methods for the estimation of procaine and diethylaminoethanol.

J Pharmacol Exp Ther. 1948 Dec;94(4):359-66.

Studies in para-aminohippuric acid synthesis in the human: its application as a liver function test.

J Clin Invest. 1950 Aug;29(8):1014-20. doi: 10.1172/JCI102332.

Studies on the metabolism of para-aminobenzoic acid.

J Pharmacol Exp Ther. 1951 Jun;102(2):98-102.

The physiological disposition and cardiac effects of procaine amide.

J Pharmacol Exp Ther. 1951 May;102(1):5-15.

Concept of a volume of distribution and possible errors in evaluation of this parameter.

J Pharm Sci. 1968 Jan;57(1):128-33. doi: 10.1002/jps.2600570125.

Procainamide dosage schedules, plasma concentrations, and clinical effects.

JAMA. 1971 Mar 1;215(9):1454-60.

Absorption, excretion, and biotransformation of procainamide-C 14 in the dog and rhesus monkey.

Arzneimittelforschung. 1971 Jul;21(7):948-51.

N-acetylprocainamide: an active metabolite of procainamide.

Proc Soc Exp Biol Med. 1974 Jun;146(2):358-63. doi: 10.3181/00379727-146-38104.

Metabolism of procainamide in rhesus monkey and man.

Clin Pharmacol Ther. 1972 May-Jun;13(3):366-71. doi: 10.1002/cpt1972133366.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献